-+ 0.00%
-+ 0.00%
-+ 0.00%

First Australian Patient Dosed in Phase 1b azer-cel Trial

ASX·01/02/2025 21:36:41

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.